ALYSE MARTIN: Open Payments
NPI 1740616192 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 30 payments from 5 companies in 2025. Trend: 2023 $545 · 2024 $1,797 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $436 |
| ABBVIE INC. | 10 | $181 |
| Novo Nordisk Inc | 1 | $123 |
| Lilly USA, LLC | 3 | $52 |
| ABIOMED | 1 | $29 |
Products named: AIRSUPRA, BREZTRI, VRAYLAR, Ozempic, FARXIGA, MOUNJARO, UBRELVY, ZEPBOUND.
Industry payments across KY — which companies pay providers there.
